Apricus Biosciences Closes $10 Million Registered Direct Offering

Apricus Biosciences, Inc. (NASDAQ:APRI) announced that it completed the subsequent closing of its previously announced registered direct offering of shares of common stock and warrants to purchase common stock.
According to the news:

The shares and warrants are being sold in combination, consisting of one share of common stock and a warrant to purchase .50 of a share of common stock, at an offering price of $0.88 for aggregate gross proceeds across all closings of approximately $10 million.
The offering was completed in separate closings. The initial closing occurred on January 13, 2016 and included gross proceeds of approximately $2.2 million from the sale of 2,528,411 shares of common stock and warrants to purchase up to 1,264,204 shares of common stock.  The subsequent closing occurred on March 3, 2016 and included gross proceeds of approximately $7.8 million from the sale of 8,835,229 shares of common stock and warrants to purchase up to 4,417,614 shares of common stock.

Click here to view the full press release.